Lumida
/NAGE
⌘K
Niagen Bioscience Inc

Niagen Bioscience Inc

NAGE
$3.04USD+0.16%+0.00 today

MARKET CAP

240.5M

P/E (TTM)

19.0x

FWD P/E

32.3x

DAY RANGE

$3 – $3

52W RANGE

$3
$11

AI Summary

Stalk
Sell NowHigh

Given the decisive break below the 3.61 support with elevated volume and extended EMAs, the downtrend remains intact across all horizons. Long-term and medium-term biases are bearish. Short-term conditions favor execution now. We will sell into the breakdown, leveraging momentum continuation dynamics.

  • Q2 revenue reached $29.8 M (+2% YoY), Tru Niagen $24.2 M (+6%).
  • E-commerce sales grew 23% YoY to $20.5 M; 10–15% growth guide.
  • Stock volatility is extremely high, deterring risk-averse investors.
Full analysis →
Insider Trades6 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 30, 2026BuyNAGERobert N FriedChief Executive Officer1,106$2.71$240.5M-71.10%+5.92%$3.0K+0.10%16bSell Now
Jun 30, 2026BuyNAGECarlos Luis LopezSVP, General Counsel2,314$2.71$240.5M-71.10%+5.92%$6.3K+102.80%16bSell Now
Jun 30, 2026BuyNAGEOzan PamirChief Financial Officer4,255$2.71$240.5M-71.10%+5.92%$11.5K+57.72%16bSell Now
Apr 24, 2026BuyNAGERobert N FriedChief Executive Officer20,000$2.61$240.5M-71.10%+5.92%$52.2K+1.92%Sell Now
Nov 14, 2025BuyNAGEOzan PamirChief Financial Officer6,685.405$6.82$240.5M-71.10%+5.92%$45.6K+229.96%Sell Now
Apr 9, 2025BuyNAGERobert N FriedChief Executive Officer66,667$3.30$240.5M-71.10%+5.92%$220.0K+6.86%Sell Now